In conclusion, we have shown here that a specific EP4 blockade by E7046 reversed the PGE2-induced myeloid-mediated immunosuppression and that E7046 + E7777 synergistically mitigated both myeloid and Treg-derived immunosuppression within the TME, to promote robust anti-tumor immune responses. Here, PTGER4 is linked to neoplasm.